Yang, Huaqing
Li, Xinyu
Que, Liping
Chen, Han
Zhan, Liping
Zhou, Dunhua
Li, Yang
Lin, Shaofen
Wang, Yin
Wu, Xiaojun
Han, Xiawei
Wu, Zhengzhou
Zhong, Danping
Huang, Ke
Xu, Honggui
Fang, Jianpei
Article History
Received: 27 September 2024
Accepted: 6 December 2024
First Online: 21 December 2024
Declarations
:
: The research protocol ‘The Impact of Modified Pretreatment Scheme on the Efficacy of Hematopoietic Stem Cell Transplantation for Treatment of Thalassemia’ was approved by the Ethics Committee of Sun Yat-sen Memorial Hospital of Sun Yat-sen University (SYSKY-2023-425-01) on 11 May 2023. Informed consent was obtained from all participants and the parents/guardians of the children under 18 years of age. This study was conducted in accordance with the Declaration of Helsinki. The protocol, amendments, and informed consent forms were approved by the appropriate institutional review board and independent ethics committee before the study began. Written informed consent was obtained from all patients prior to enrolment.
: The authors have declared that no conflicts of interest. No financial or non-financial benefits have been received or will be received from any party directly or indirectly related to the subject of this article.